See Full Prescribing Information & Boxed Warning at the Official Physician Site. Review Our Studies Regarding Survival Rate ...
View Prescribing Info and Boxed Warning. Understand The Possible Side Effects. Visit The Patient Site To Get More Information About This FDA-Approved Treatment Option. Side Effect Info.
Regorafenib
Drug
Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase. Regorafenib shows anti-angiogenic activity due to its dual... Wikipedia
ATC code: L01EX05 (WHO)
Bioavailability: 69-83%
Elimination half-life: 20-30 hours
Other names: BAY 73-4506